Cargando…

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

Objective To assess the thrombotic risk associated with oral contraceptive use with a focus on dose of oestrogen and type of progestogen of oral contraceptives available in the Netherlands. Design Population based case-control study. Setting Six participating anticoagulation clinics in the Netherlan...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Hylckama Vlieg, A, Helmerhorst, F M, Vandenbroucke, J P, Doggen, C J M, Rosendaal, F R
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726929/ https://www.ncbi.nlm.nih.gov/pubmed/19679614 http://dx.doi.org/10.1136/bmj.b2921

Ejemplares similares

Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis
por: Stegeman, Bernardine H, et al.
Publicado: (2013)

Effectiveness and acceptability of progestogens in combined oral contraceptives – a systematic review
por: Kulier, Regina, et al.
Publicado: (2004)

Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
por: Lidegaard, Øjvind, et al.
Publicado: (2011)

Glucose levels and diabetes are not associated with the risk of venous thrombosis: results from the MEGA case‐control study
por: Li‐Gao, Ruifang, et al.
Publicado: (2018)

The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk
por: Khialani, Deeksha, et al.
Publicado: (2020)

Statin use and risk of recurrent venous thrombosis: results from the MEGA follow‐up study
por: Brækkan, Sigrid K., et al.
Publicado: (2017)

Progestogen-only oral contraceptives: Number 4 - April 2022
por: Machado, Rogério Bonassi, et al.
Publicado: (2022)

Travel-Related Venous Thrombosis: Results from a Large Population-Based Case Control Study (MEGA Study)
por: Cannegieter, Suzanne C, et al.
Publicado: (2006)

Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)
por: Timp, Jasmijn F., et al.
Publicado: (2019)

Association of Remote History of Venous Thrombosis With Risk of Venous Thrombosis After Age 70 Years
por: Wang, Huijie, et al.
Publicado: (2022)

Correction: Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)
por: Timp, Jasmijn F., et al.
Publicado: (2021)

Procoagulant factor levels and risk of venous thrombosis in the elderly
por: Wang, Huijie, et al.
Publicado: (2020)

Association between cardiovascular risk factors and venous thromboembolism in the elderly
por: Wang, Huijie, et al.
Publicado: (2022)

D‐dimer, thrombin generation, and risk of a first venous thrombosis in the elderly
por: Wang, Huijie, et al.
Publicado: (2021)

Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?
por: Nappi, Rossella E, et al.
Publicado: (2013)

Differences in oestrogen receptors in malignant and normal breast tissue as identified by the binding of a new synthetic progestogen.
por: Iqbal, M. J., et al.
Publicado: (1986)

Long-Term Survival in a Large Cohort of Patients with Venous Thrombosis: Incidence and Predictors
por: Flinterman, Linda E., et al.
Publicado: (2012)

Health-related quality of life after first venous thromboembolism in individuals aged 70 years and older
por: Wang, Huijie, et al.
Publicado: (2023)

The clinical relevance of progestogens in hormonal contraception: Present status and future developments
por: Regidor, Pedro-Antonio
Publicado: (2018)

Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer
por: Gallez, Anne, et al.
Publicado: (2021)

ODP644 Oral Dosing of Progestogenic Androgens for Male Contraception Show Low Serum Testosterone and High Acceptability in Placebo-Controlled Trials
por: Jacobsohn, Tamar, et al.
Publicado: (2022)

Lipid levels and risk of venous thrombosis: results from the MEGA-study
por: Morelli, Vânia M., et al.
Publicado: (2017)

Progesterone and progestogens
por: Lipinski, Joanne
Publicado: (2022)

Agreement of aptamer proteomics with standard methods for measuring venous thrombosis biomarkers
por: Faquih, Tariq, et al.
Publicado: (2021)

Whole exome sequencing in thrombophilic pedigrees to identify genetic risk factors for venous thromboembolism
por: Cunha, Marisa L. R., et al.
Publicado: (2017)

CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk
por: Garcia-Albeniz, Xabier, et al.
Publicado: (2016)

FFP2-mondmasker of chirurgisch mondkapje bij COVID-19
por: van Hylckama Vlieg, Astrid, et al.
Publicado: (2020)

Endogenous sex hormones and risk of venous thromboembolism in young women
por: Scheres, Luuk J. J., et al.
Publicado: (2019)

Factor V levels and risk of venous thrombosis: The MEGA case‐control study
por: Rietveld, Inge M., et al.
Publicado: (2018)

Sex‐specific aspects of venous thromboembolism: What is new and what is next?
por: Scheres, Luuk J. J., et al.
Publicado: (2022)

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy
por: Douxfils, Jonathan, et al.
Publicado: (2023)

Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings
por: Bińkowska, Małgorzata, et al.
Publicado: (2022)

Progestogens in menopausal hormone therapy
por: Bińkowska, Małgorzata, et al.
Publicado: (2015)

Bridging progestogens in pregnancy and pregnancy prevention
por: Micks, Elizabeth, et al.
Publicado: (2015)

The Use of Progestogen in the Treatment of Metastatic Carcinoma of the Kidney and Uterine Body
por: Paine, C. H., et al.
Publicado: (1970)

From Research to Policy: The WHO Experience With Developing Guidelines on the Potential Risk of HIV Acquisition and Progestogen-Only Contraception Use
por: Han, Leo, et al.
Publicado: (2017)

Low dose combined oral contraceptives induced thrombotic anterior wall myocardial infarction: a case report
por: Rahhal, Alaa, et al.
Publicado: (2020)

The Role Of Progestogens In Threatened And Idiopathic Recurrent Miscarriage
por: Arab, Hisham, et al.
Publicado: (2019)

Solving the Puzzle: What Is the Role of Progestogens in Neovascularization?
por: Xia, Zhi, et al.
Publicado: (2021)

Synergistic Effects of Hypofibrinolysis and Genetic and Acquired Risk Factors on the Risk of a First Venous Thrombosis
por: Meltzer, Mirjam E, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_r41alv33tvsis4assujdqe4gbi